about
Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees.Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice.Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in mice.Sunitinib DDI with paracetamol, diclofenac, mefenamic acid and ibuprofen shows sex-divergent effects on the tissue uptake and distribution pattern of sunitinib in mice.Advances in studies of tyrosine kinase inhibitors and their acquired resistance.Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Sunitinib Possible Sex-Divergent Therapeutic Outcomes.
@en
type
label
Sunitinib Possible Sex-Divergent Therapeutic Outcomes.
@en
prefLabel
Sunitinib Possible Sex-Divergent Therapeutic Outcomes.
@en
P2860
P1476
Sunitinib Possible Sex-Divergent Therapeutic Outcomes.
@en
P2093
Cecilia Fernández
Pilar Modamio
P2860
P304
P356
10.1007/S40261-016-0428-5
P577
2016-06-18T00:00:00Z